Market Overview:
The global external neuromodulation market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of neurological disorders, technological advancements in neuromodulation devices, and rising demand for minimally invasive procedures. The global external neuromodulation market is segmented by type, application, and region. By type, the market is divided into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), respiratory electrical stimulation (RES), and others. TENS is further sub-segmented into low-frequency TENS and high-frequency TENS. By application, the market is classified into spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation (SNS), and others. SCS accounted for the largest share of the global external neuromodulation market in 2017 owing to its widespread use in treating chronic pain conditions such as neuropathic pain and failed back surgery syndrome. DBS was second largest application segment due to its increasing use in treating various movement disorders such as Parkinson’s disease, essential tremor, dystonia etc. the third largest segment was SNS which used for urinary incontinence & fecal incontinence treatment .
Product Definition:
External neuromodulation is the process of applying electrical current or magnetic fields to the brain in order to change its function. It can be used to treat conditions such as depression, anxiety, and chronic pain, as well as to improve cognitive function.
Transcutaneous Electrical Nerve Stimulation:
Transcutaneous Electrical Nerve Stimulation (TENS) is a non-invasive technique that delivers low-level electrical stimulation to the nerves outside of the brain and spinal cord. The electrical signal is sent to modulate pain by changing the neural transmission at a cellular level. TENS devices are used for various medical conditions such as failed back syndrome, neck and face pain, fibromyalgia, arthritis pain etc., etc.
Transcranial Magnetic Stimulation:
Transcranial Magnetic Stimulation (TCMS) is a non-invasive technique that uses magnetic fields to modulate brain activity. It's main objective is to stimulate nerve cells in the vicinity of the skull using electromagnetic energy, thereby creating new neural pathways and increasing cognitive flexibility. TCMS allows stimulating any part of the brain by using both anode and cathode devices that generate magnetic fields directed towards or away from the scalp depending on which part of the brain needs stimulation.
Application Insights:
On the basis of application, the global external neuromodulation market is segmented into spinal cord stimulation, deep brain stimulation, others and transcutaneous electrical nerve stimulation. Transcutaneous electrical nerve stimulation held the largest share in 2017 due to its non-invasive nature and ability to treat multiple sclerosis. On the other hand, deep brain Stimulation is expected to grow at a higher rate during forecast period owing to its high therapeutic value in neurological disorders such as Parkinson¢â‚¬â„¢s disease and epilepsy.
Spinal cord Stimulation involves stimulating nerves that exit from below the skull through holes called foramen magnum on either side ofthe head.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of neurological disorders, availability of highly skilled physicians, and increasing government initiatives. For instance, North American Neuromodulation Association (NANA) was formed by leading companies for improving patient access to neuromodulation devices. The organization helps patients find resources about treatment options and providers through its online database.
Asia Pacific is expected to grow at a lucrative rate over the forecast period due to rising disposable income coupled with growing awareness among people about available treatments for various diseases including Parkinson’s disease & Huntington’s disease.
Growth Factors:
- Increasing demand for non-invasive and minimally invasive treatments for various neurological disorders.
- Growing geriatric population base with rising prevalence of neurological disorders.
- Rising awareness about the benefits of external neuromodulation therapies among patients and healthcare professionals.
- Technological advancements in external neuromodulation devices and therapies.
- increasing funding for research on external neuromodulation therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
External Neuromodulation Market Research Report
By Type
Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, Respiratory Electrical Stimulation
By Application
Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Others
By Companies
Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US), Cyberonics, Inc. (US), BioControl Medical (Israel)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global External Neuromodulation Market Report Segments:
The global External Neuromodulation market is segmented on the basis of:
Types
Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, Respiratory Electrical Stimulation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic, Inc. (US)
- Boston Scientific Corporation (US)
- St. Jude Medical, Inc. (US)
- Synapse Biomedical, Inc. (US)
- Nevro Corporation (US)
- Neurosigma, Inc. (US)
- Neuropace, Inc. (US)
- Neuronetics, Inc. (US)
- Cyberonics, Inc. (US)
- BioControl Medical (Israel)
Highlights of The External Neuromodulation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
- By Application:
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the External Neuromodulation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
External neuromodulation is a type of medical treatment that uses electrical or magnetic stimulation to alter the activity of specific nerve cells in the brain. This can be done to treat conditions like depression, anxiety, and chronic pain.
Some of the major players in the external neuromodulation market are Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US), Cyberonics, Inc. (US), BioControl Medical (Israel).
The external neuromodulation market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 External Neuromodulation Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 External Neuromodulation Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 External Neuromodulation Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the External Neuromodulation Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global External Neuromodulation Market Size & Forecast, 2020-2028
4.5.1 External Neuromodulation Market Size and Y-o-Y Growth
4.5.2 External Neuromodulation Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Transcutaneous Electrical Nerve Stimulation
5.2.2 Transcranial Magnetic Stimulation
5.2.3 Respiratory Electrical Stimulation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Spinal Cord Stimulation
6.2.2 Deep Brain Stimulation
6.2.3 Sacral Nerve Stimulation
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global External Neuromodulation Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 External Neuromodulation Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Transcutaneous Electrical Nerve Stimulation
9.6.2 Transcranial Magnetic Stimulation
9.6.3 Respiratory Electrical Stimulation
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Spinal Cord Stimulation
9.10.2 Deep Brain Stimulation
9.10.3 Sacral Nerve Stimulation
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Transcutaneous Electrical Nerve Stimulation
10.6.2 Transcranial Magnetic Stimulation
10.6.3 Respiratory Electrical Stimulation
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Spinal Cord Stimulation
10.10.2 Deep Brain Stimulation
10.10.3 Sacral Nerve Stimulation
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Transcutaneous Electrical Nerve Stimulation
11.6.2 Transcranial Magnetic Stimulation
11.6.3 Respiratory Electrical Stimulation
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Spinal Cord Stimulation
11.10.2 Deep Brain Stimulation
11.10.3 Sacral Nerve Stimulation
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Transcutaneous Electrical Nerve Stimulation
12.6.2 Transcranial Magnetic Stimulation
12.6.3 Respiratory Electrical Stimulation
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Spinal Cord Stimulation
12.10.2 Deep Brain Stimulation
12.10.3 Sacral Nerve Stimulation
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Transcutaneous Electrical Nerve Stimulation
13.6.2 Transcranial Magnetic Stimulation
13.6.3 Respiratory Electrical Stimulation
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Spinal Cord Stimulation
13.10.2 Deep Brain Stimulation
13.10.3 Sacral Nerve Stimulation
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 External Neuromodulation Market: Competitive Dashboard
14.2 Global External Neuromodulation Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic, Inc. (US)
14.3.2 Boston Scientific Corporation (US)
14.3.3 St. Jude Medical, Inc. (US)
14.3.4 Synapse Biomedical, Inc. (US)
14.3.5 Nevro Corporation (US)
14.3.6 Neurosigma, Inc. (US)
14.3.7 Neuropace, Inc. (US)
14.3.8 Neuronetics, Inc. (US)
14.3.9 Cyberonics, Inc. (US)
14.3.10 BioControl Medical (Israel)
